Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 990

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 990
---
II-3

#### ExhibitNumberDescription10.20Amendment No. 1 to Master Services Agreement, dated as of April 26, 2018, by and between Semnur Pharmaceuticals, Inc. and Lifecore Biomedical, LLC.10.21^Amendment No. 2 to Master Services Agreement, dated as of June 6, 2023, by and between Semnur Pharmaceuticals, Inc. and Lifecore Biomedical, LLC.10.22Assignment Agreement by and among Shah Investor LP and the Company, dated as of August 6, 2013.10.23Advisory Services Agreement, dated as of August 26, 2024, by and between Wise Orient Investments Limited and Semnur Pharmaceuticals, Inc.10.24Advisory Services Agreement, dated as of August 25, 2024, by and between 450W42ND MIMA, LLC and Semnur Pharmaceuticals, Inc.10.25#Third Amended and Restated Convertible Promissory Note, dated as of January 24, 2025, issued by Denali Capital Acquisition Corp. to Denali Capital Global Investments LLC.16.1Letter Regarding Change in Accountants (incorporated by reference to Exhibit 16.1 to Denali’s Current Report on Form8-Kfiled with the SEC on July 17, 2024).21.1List of Subsidiaries of the Registrant.23.1Consent of Marcum Asia CPAs LLP, independent registered public accounting firm of Denali Capital Acquisition Corp.23.2Consent of Marcum LLP, former independent registered public accounting firm of Denali Capital Acquisition Corp.23.3Consent of Pipara & Co LLP, independent registered public accounting firm of Semnur.23.4+Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit 5.1).23.5+Consent of Winston & Strawn LLP (included in Exhibit 5.2 and 8.1).24.1Power of Attorney (included on the signature page to this proxy statement/prospectus).99.1Consent of Henry Ji to be named as a director nominee.99.2Consent of Jaisim Shah to be named as a director nominee.99.3Consent of Jay Chun to be named as a director nominee.99.4Consent of Dorman Followwill to be named as a director nominee.99.